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Réu et al. show that human microglia,
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lineages, slowly turn over at a yearly
median rate of 28%. The absence of a
large quiescent subpopulation indicates
that most microglia will renew throughout
life.
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The hematopoietic system seeds the CNS with mi-
croglial progenitor cells during the fetal period, but
the subsequent cell generation dynamics and main-
tenance of this population have been poorly under-
stood. We report that microglia, unlike most other
hematopoietic lineages, renew slowly at a median
rate of 28% per year, and some microglia last for
more than two decades. Furthermore, we find no
evidence for the existence of a substantial popula-
tion of quiescent long-lived cells, meaning that the
microglia population in the human brain is sustained
by continuous slow turnover throughout adult life.INTRODUCTION
Microglia are the resident macrophages of the CNS, which
dynamically survey their surrounding for signs of infection or
cell distress (Casano and Peri, 2015). In mice, microglial progen-
itor cells derive from an early myeloid branch of the hematopoi-
etic lineage in the embryonic yolk sac and enter the CNS before
the blood-brain barrier is formed (Ginhoux et al., 2010; Schulz
et al., 2012). There is no further contribution from the peripheral
hematopoietic system under physiological conditions, and this is
a self-sustaining population within the CNS (Ajami et al., 2007;
Askew et al., 2017; Bruttger et al., 2015; Hoeffel et al., 2015;
Mildner et al., 2007). The self-contained nature of this population
makes it vulnerable to local disturbances. Additionally, it is key
for brain homeostasis that microglial cell numbers are stably
maintained, because having reduced numbers results in behav-
ioral and learning deficits (Parkhurst et al., 2013).
Based on [3H]thymidine incorporation, heavy water (2H2O)
labeling, and 5-ethynyl-20-deoxyuridine (EdU) and 5-bromo-20-
deoxyuridine (BrdU) incorporation, 0.075%–1.04% of microglia
in adult mice of different strains and 2.35% of microglia in the
young adult macaque were estimated to enter the cell cycle
each day (Askew et al., 2017; Lawson et al., 1992; Shankaran
et al., 2007; Tay et al., 2017; Tonchev et al., 2003). It is difficultThis is an open access article undto infer cell turnover dynamics in humans from data in experi-
mental animals, which may have very different requirements or
lifespans. Assessing the turnover of human immune cells is
notably important because it is particularly hard to deduce
renewal rates from laboratory animals, which live in pathogen-
free barrier facilities (Beura et al., 2016). A recent study demon-
strated that 2% of microglia in the adult human brain are in cell
cycle at any given time based on Ki-67 labeling, but the authors
noted the limitations of this approach and acknowledge the
need for more precise measurements (Askew et al., 2017). It is
difficult to estimate cell turnover dynamics based on cell cycle
markers, because it rests on assumptions of cell cycle length.
Moreover, it is not possible to know whether the cell will proceed
through the cell cycle to mitosis or whether the potential progeny
will survive.RESULTS
We analyzed the frontal and occipital cortices from two subjects
(17 and 41 years old) who had received IdU (5-Iodo-20-deoxyur-
idine) as a radiosensitizer for cancer treatment (Table S1). On
average, 0.8% of Iba1+ parenchymal microglia in the cortex
were IdU+ after 4 days (donor 1) or 10 days (donor 2) of IdU
administration (Figures 1A and 1B; Table S1). Accounting
for the labeling period, it averages at 0.14% labeling per day
(Figure 1C). These observations do, however, come with the
following caveats: (1) the sample size is small and additional
samples are not available; and (2) the subjects studied are not
healthy individuals, and thus may exhibit aberrant turnover of
different populations of cells. Still, our observations provide us
with a general estimate of what to expect in our downstream
analysis based on retrospective 14C measurements.
Following CD11b magnetic bead selection, we isolated
by fluorescence-activated cell sorting (FACS) CD45+/CD11b+
microglia from the adult human postmortem cerebral cortex
in order to perform retrospective 14C dating (Figures 2A–2C)
(Olah et al., 2012). We used CD20, a B cell marker, to evaluate
the presence of blood-borne cells in dissociated cortical prepa-
rations. The percentage of B cells in brain samples prior toMACS
purification (Figure 2D) is very low relative to the circulationCell Reports 20, 779–784, July 25, 2017 ª 2017 The Author(s). 779
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. IdU Incorporation
(A) Confocal image with orthogonal projections, from human cortex, revealing microglia positive for Iba1.
(B) Co-staining of Iba1 and the thymidine analog IdU.
(C) Percentage of microglia incorporating IdU per day (mean ± SD). Each data point represents a glass slide. Nuclei are labeled with antibodies to histone H3.
Scale bars, 10 mm.(Figure 2E), indicating that contamination by blood-borne cells is
likely to be a negligible factor. The average postmortem interval
of our donors is 43 hr, and it is likely that most blood has coag-
ulated inside the vessels. Nonetheless, we decided to experi-
mentally address the possible contamination with peripheral
monocytes, which also express CD45 and CD11b. To do
so, we isolated CD11b+ cells from peripheral blood with mag-
netic beads, following the same positive selection protocol we
used to isolate microglia from dissociated cortical specimens,
and labeled them with carboxyfluorescein succinimidyl ester
(CFSE). We then prepared a mixed sample containing both
CD11b+/CFSE+ blood cells and CD11b+ microglia isolated in
parallel (Figure 2F). This allowed us to simultaneously label and
visualize both populations in a single sample, ruling out variability
in labeling protocols. Microglia were found to exhibit lower
expression of CD45 and did not overlap with blood-borne cells,
further suggesting that cells from the blood are not likely to be a
significant source of contamination, because cells with higher
CD45 expression were excluded in all experiments (Figure 2G).
We confirmed the identity of the isolated microglial cells by
qPCR using Iba1, CD11b, and CD45 (Tambuyzer et al., 2009),
and found only minimal contamination of neurons (NeuN), astro-
cytes (GFAP), or oligodendrocytes (MBP) (Figure 2H). As ex-
pected, the sorted cells are positive for the microglial marker
Iba-1 (Figure 2I).
By relating the 14C level in the DNA of cells to the atmospheric
14C curve, one can determine the average date of birth of the cell
population (Spalding et al., 2005) (Figure 3A). Using this strategy,
we performed retrospective birth dating of microglia isolated
from adults born across six decades (Figure 3B; Table S2).
Based on the year of collection and date of birth of the sample,
it is possible to calculate the average cell age of the sample (Fig-
ure 3C). Using a homogeneous turnover model in which each cell
is replaced at a fixed rate, it is possible to obtain robust snap-
shots of cell dynamics for each individual donor (Bernard et al.,
2010). In simple terms, this is accomplished by calculating how
often cells need to divide within an individual of a given age in or-780 Cell Reports 20, 779–784, July 25, 2017der for the cells to have the measured 14C level. If cells are as old
as the individual, their renewal rate is zero and the measured 14C
level corresponds to the level at birth. In mice, under homeo-
static conditions, microglia have been shown to have a stable
network and to self-renew stochastically (Tay et al., 2017). Simi-
larly, in the homogeneous turnover model, all cells are equally
likely to be replaced (Supplemental Information). Our results indi-
cate that themajority ofmicroglia in the healthy human cortex are
replaced by newly produced cells at a median rate of 28% per
year (or 0.08% per day), and that they have an average age of
4.2 years (Figure 3C; Table S2). This is a lower rate than esti-
mated by IdU incorporation (0.14% per day; Figure 1C). The dif-
ference may indicate that the microglial population is somewhat
heterogeneous because a pulse of IdU preferentially labels a
more rapidly dividing subpopulation.
Cells that became postmitotic soon after birth have a unique
14C signature, corresponding to the atmospheric level at that
moment in time. This allowed us to directly investigate the
possible existence of a non-dividing subpopulation, using a het-
erogeneous turnover model (Figure 3D). The model that best fits
our data are one where the majority of the population (>96%)
is renewed and we have no evidence to support the existence
of a significant subpopulation of quiescent very long-lived cells
(Figure 3D). We have employed a conservative mathematical
model, with few assumptions, which does not preclude that an
extended dataset or other variables could explain the heteroge-
neity observed.
Based on the average cell age and cell division rate observed,
we generated cell age distributions stochastically, showing that
within an individual there is a wide range of microglia ages (Fig-
ure 3E). Simply because not all cells are dividing at the same
time, some are quite young due to recent cell division and others
can be more than 20 years old (Figure 3E).
The lower rate of microglia renewal compared with most other
immune cells is probably a manifestation of the immune-privi-
leged status of the CNS (Figure 3F) (Busch et al., 2007; Macallan
et al., 2005). On the other hand, in comparison with other cells of
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Figure 2. Microglia Isolation
(A) Unstained brain single-cell suspension
following CD11b isolation with magnetic beads.
(B) Sorting gate for FACS sorting of stained mi-
croglial cells.
(C) Representative post-sort purity of microglia
sample.
(D) FACS plot representing the percentage of
positive cells for the B cell marker CD20 in a brain
sample prior to MACS purification.
(E) FACS plot representing the percentage of
positive cells for CD20 in a sample of peripheral
blood.
(F) Blood cells were positively selected with
CD11b microbeads, labeled with CFSE (red gate),
and then spiked into a brain preparation previously
selected with CD11b microbeads.
(G) Gating strategy for the sorting of microglia
(spiked blood cells in red).
(H) qRT-PCR reveals that, when compared with
the magnetic bead negative fraction, the FACS
sorted microglia sample is several hundred-fold
enriched for mRNA of the microglia markers Iba1,
CD11b, and CD45 and depleted of mRNA for
markers of neurons (NeuN), astrocytes (GFAP),
and oligodendrocytes (MBP).
(I) FACS sorted cells are positive for the microglial
marker Iba-1 (A488). Scale bar, 10 mm.the CNS, microglia show a high exchange rate (Figure 3F)
(Spalding et al., 2005, 2013; Yeung et al., 2014). Thus, a constant
basal renewal is likely necessary for the maintenance of a cohort
of young and healthy microglial cells.
DISCUSSION
Administering nucleotide analogs for a short time period intro-
duces a bias to label the cells with the highest proliferation rate
within a potentially heterogeneous population. Also, labeled cells
that continue to proliferate after the labeling period will give rise
to additional positively labeled cells that lead to overestimations
of cell proliferation (Neese et al., 2002). Nevertheless, samples of
human brain labeled with nucleotide analogs are very valuable,
not only due to their rarity but also as a confirmatory tool of in vivoC
renewal in humans (Eriksson et al., 1998;
Ernst et al., 2014; Yeung et al., 2014).
Analysis of the integration of atmo-
spheric 14C, derived from nuclear bomb
tests, in genomic DNA is cumulative and
gives a more comprehensive view of cell
age and cell division history (Spalding
et al., 2005), and it is possible to analyze
tissue from subjects without previous
serious illness. There is little exchange
of carbon atoms in genomic DNA in
non-dividing cells, and the effect of DNA
repair and methylation is well below the
detection limit of this retrospective birth
dating strategy (Bergmann et al., 2012;
Ernst et al., 2014; Spalding et al., 2005),even after, for example, stroke, where there is a substantial in-
crease in DNA damage and repair (Huttner et al., 2014).
Most immune cells do not live longer than a few days or weeks
(Busch et al., 2007; Macallan et al., 2005), making microglia
one of the slowest dividing immune cells described to date. An
extreme exception is plasma cells in the intestine, where the sub-
set with the slowest renewal rate has a median age of 22 years
(Landsverk et al., 2017). The turnover rate of microglia in humans
is substantially lower than in mice. There is a much higher ex-
change of oligodendrocytes in mice compared with humans
(Yeung et al., 2014), and it is possible that clearance of myelin
and cell debris calls for a higher exchange rate of microglia in
mice.
Based on Ki-67 staining, a recent study estimated that, at
any given moment, 2% of microglia are proliferating in theell Reports 20, 779–784, July 25, 2017 781
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Figure 3. Microglial Population Dynamics
(A) Schematic illustration of the 14C atmospheric curve over time (Levin et al., 2010). The concentration of 14C in the genomic DNA of a cell population is dependent
on the atmospheric 14C concentration (y axis). Thus, the birth date of the cell population can be read off the x axis.
(B) 14C content in the genomic DNA of human cortical microglia from donors born across six decades. Data points plotted along the x axis according to the date of
birth of the donors. Close-up view of four nearly overlapping data points (gray square). The error bars represent the 14C concentration measurement error.
(C) Representation of the average age of microglia in each individual and linear regression (black line).
(D) Different models for distribution of data on the atmospheric 14C curve considering different frequencies of dividing cells. The model that best fits the data are
one where most cells (>96%) renew.
(E) Considering the turnover rate, the average cell age, and the fact that all microglial cells do not divide simultaneously, we created a stochastic cell age
distribution model. Our model shows that within an individual there is a distribution of cells of different ages, with some having recently renewed and others not
having divided in more than 20 years (donors with infinite turnover not included).
(F) The approximate rate of microglia turnover is 0.08% a day, a low turnover rate in comparison with other immune cells (granulocytes, monocytes, and naive
B cells) but a high turnover rate relative to other CNS cells (neurons in the dentate gyrus, oligodendrocytes, and cortical neurons).human brain (Askew et al., 2017). Similarly to short-term label-
ing experiments using BrdU or IdU, Ki-67 staining detects
dividing cells, but it provides limited information for cells that
may exhibit slow renewal rates. Importantly, Ki-67 does not
measure proliferation directly, and cells blocked in G1 or
destined to enter apoptosis can accumulate in the population
as Ki-67+ events because of a G1/S block (Busch et al.,
2007). An additional explanation for the results of the different
techniques resides in the fact that newborn microglia are
more likely to die than the resident microglia (Askew et al.,
2017). Hence, many of the cells detected by Ki-67 and, to a
lesser extent, by IdU may be destined to die and not to replace
existing ones.
In conclusion, 14C analyses reveal that microglia as a whole
turn over slowly, and that individual cells can potentially be
decades old. Complementary, IdU and Ki-67 (Askew et al.,
2017) measurements suggest heterogeneity within the popula-
tion possibly induced by the presence of a subpopulation of
fast dividing cells. Finally, our data predict a nearly complete
renewal of the microglia population in the human cortex during
the lifespan of an individual, similar to what has been seen in
mice (Askew et al., 2017).782 Cell Reports 20, 779–784, July 25, 2017EXPERIMENTAL PROCEDURES
Tissue Collection
Neocortical tissue was obtained from donors admitted for autopsy at the
Department of Forensic Medicine in Stockholm from 2014 to 2016, after
informed consent from the relatives. The ethical permit for this study was
granted by the Regional Ethics Committee of Stockholm (2010/313-31/3).
Formalin-fixed and paraffin-embedded sections of cortical frontal lobe and
occipital lobe from cancer patients, who had received IdU for therapeutic
purposes, were obtained from the National Heart, Lung and Blood Institute,
NIH. Buffy coats were obtained from anonymous regular blood donors at
Blodcentralen, Karolinska University Hospital.
IdU Quantification
The sections were immersed in xylene to remove the paraffin, and the tissue
was rehydrated in descending ethanol series. Triton X-100 (0.2%) was used
to permeabilize the tissue, and antigen retrieval was performed in 0.05% citra-
conic acid solution (pH 7.4) for 20 min in a domestic steamer. The sections
were left for 20 min at room temperature and then immersed in 2.0 N HCl for
40 min. The slides were blocked (10% donkey normal serum in PBS with
0.2% Triton X-100) at room temperature for 1 hr. Following incubation with
the primary antibodies (1:60 mouse anti-BrdU, BD347580; 1:100 goat anti-
Histone H3, Abcam 12079; 1:100 rabbit anti-Iba1, Wako 019-19741), the sec-
tions were incubated with the secondary antibodies (1:200 donkey anti-mouse
Cy3, Jackson ImmunoResearch 715-165-150; 1:200 donkey anti-goat A647,
Jackson ImmunoResearch 705-605-147; 1:200 donkey anti-rabbit A488,
Jackson ImmunoResearch 711-545-152) and inspected in an LSM 700 (Carl
Zeiss) confocal microscope. The percentage of IdU+ microglia in each slide
was found based on the total number of Iba+ cells and the number of Iba1+/
IdU+ cells. By dividing the percentage of labeled cells by the number of labeling
days (4 for donor 1 and 10 for donor 2), we calculated the daily labeling. The
raw data and the calculations are in Table S1.
Tissue Dissociation
After careful removal of the meninges and all visible blood vessels, the tissue
was cut into small pieces and thoroughly rinsed with PBS. The tissue was then
homogenized in media A (13 HBSS, 150 mM HEPES, 2 mM EDTA, 5% BSA)
with 2 U/mL papain (Worthington) and 10 U/mL DNaseI (Roche) at 37C for
1.5 hr. The homogenized tissue was mix with 3 volumes of sucrose media I
(PBS, 0.7 M sucrose, 2 mM EDTA) and centrifuged for 20 min at 1,000 3 g.
The pellet was then resuspended in sucrose media II (PBS, 0.9 M sucrose,
2 mM EDTA) and centrifuged for 25 min at 800 3 g. Finally the pellet was
resuspended in blocking solution (PBS, 0.1% FBS, 2 mM EDTA) and filtered
through a 40 mm cell strainer.
Cell Isolation
The cell suspension was incubated for 5 min with human Fc-gamma receptor
(FcR)-binding inhibitor (1:100; eBioscience) and for 30 min with CD11b
antibody-conjugated microbeads (1:25, 130-093-634; Miltenyi Biotec). The
magnetic isolation was performed according to the manufacturer. The sam-
ples were next incubated for 20 min with PE-CD11b (1:20, clone ICRF44;
BioLegend) and Alexa 647 CD45 (1:20, clone HI30; BioLegend), and finally
FACS sorted in an Influx flow cytometer (BD Biosciences). Blood cells were
isolated from buffy coats by density gradient (Lymphoprep). Peripheral blood
mononuclear cells (PBMCs) were positively selected with CD11b antibody-
conjugated microbeads (1:25, 130-093-634; Miltenyi Biotec) according to
the manufacturer.
DNA Isolation
In order to prevent carbon contaminations, weperformed theDNA isolation in a
clean room (ISO8). The extraction protocol was modified from Miller et al.
(1988). The glassware was prebaked for 4 hr at 450C. 1 mL of lysis buffer
(100 mM Tris [pH 8.0], 200 mM NaCl, 1% SDS, and 5 mM EDTA) and 12 mL
of Proteinase K (40 mg/ml) were added to the sorted cells and incubated at
65C overnight. The samples were further incubated at 65C for 1 hr after
6 mL of RNase cocktail (Ambion) was added. 600 mL of NaCl (5 M) was added
to the sample; then it was vortexed for 30 s. The solution was spun down at
13,000 rpm for 6 min. The supernatant containing the DNA was transferred to
a 12mLglass vial. Ethanol 95% (6mL) was added and the glass vial wasmanu-
ally agitated. The DNA precipitate was washed three times in DNA washing
buffer (70% ethanol [v/v] and 0.5 M NaCl), dried at 65C overnight, and resus-
pended in 0.5mLDNase/RNase freewater (GIBCO/Invitrogen). TheDNApurity
and concentration were verified by UV spectroscopy (NanoDrop).
Accelerator Mass Spectrometry
DNA samples suspended in 0.5 mL of water were lyophilized to dryness in a
vacuumcentrifuged at 2,000 rpm for 2 hr. To convert the samples into graphite,
we added excess CuO to each dry sample, and the quartz tubes were evacu-
ated and sealed with a high temperature torch. The tubes were placed in a
furnace set at 900C for 3 hr to combust all carbon to CO2. The gas was
then purified by freezing the residual water at 80C, as well as cryogenically
trapping the CO2 at 196C and discarding all the other gases. The CO2 was
chemically reduced to graphite in the presence of zinc powder and iron cata-
lyst in individual miniaturized reactors at 550C for 6 hr. Thorough laboratory
protocols are exercised to minimize the introduction of stray carbon into the
sample (Salehpour et al., 2013a). Graphite targets were pressed into individual
cathodes and are measured at the Department of Physics and Astronomy, Ion
Physics, Uppsala University (Salehpour et al., 2013a, 2013b, 2015) using the
5 MV Pelletron Tandem accelerator. Large CO2 samples (>100 mg) may be
split, and d13C are measured by stable isotope ratio mass spectrometry, which
established the d13C correction to 24.1& ± 0.5& (1 SD), which was applied
to the samples. Corrections for background carbon introduced during samplepreparation were made as described previously (Salehpour et al., 2013a,
2013b, 2015). The measurement error was determined for each sample and
ranged between ±8& and 40& (2 SD)D14C for the large (>100mgC) and small
samples (10 mgC), respectively. All 14C data are reported as FractionModern F
14C as defined in Reimer et al. (2004) or D14C as defined in Stuiver and Polach
(1977). All accelerator mass spectrometry (AMS) analyses were performed
blind to the identity of the sample.
qRT-PCR
qRT-PCR was performed using TaqMan gene expression assays (RBFOX3,
4331182; AIF-1, 4331182; ITGAM, 4331182; PTPRC, 4331182; GAPDH,
4331182; and MBP, 4331182).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two tables and can be found with this article online at http://dx.doi.org/
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curing tissue, and Karl Håkansson and Peter Senneryd for AMS sample prep-
aration. This study was supported by grants from the Swedish Research
Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftel-
sen, the ERC, Knut och Alice Wallenbergs Stiftelse, and Torsten Söderbergs
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